Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial

The triplet combination of irinotecan, oxaliplatin and fluorouracil is an active frontline regimen in metastatic colorectal cancer, but scarce data exist on its use as salvage treatment. We aimed at assessing its safety and efficacy profiles with its circadian‐based administration (chronoIFLO5) as e...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Cancer
Главные авторы: Innominato, Pasquale F., Karaboué, Abdoulaye, Focan, Christian, Chollet, Philippe, Giacchetti, Sylvie, Bouchahda, Mohamed, Ulusakarya, Ayhan, Torsello, Angela, Adam, René, Lévi, Francis A., Garufi, Carlo
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons, Inc. 2020
Предметы:
Cancer Therapy and Prevention
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8048520/
https://ncbi.nlm.nih.gov/pubmed/33270911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.33422
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы